Antimicrobial resistance of Shigella sonnei in Korea during the last two decades
Eighty-eight strains of Shigella sonnei isolated in Korea during the period 1980 to 1999 were tested for susceptibility to 13 antimicrobial agents. S. sonnei isolates demonstrated high frequencies of resistance to sulfamethoxazole (97.7%), tetracycline (96.6%), and trimethoprim (95.5%). S. sonnei is...
Gespeichert in:
| Veröffentlicht in: | APMIS : acta pathologica, microbiologica et immunologica Scandinavica microbiologica et immunologica Scandinavica, 2001-03, Vol.109 (3), p.228-234 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 234 |
|---|---|
| container_issue | 3 |
| container_start_page | 228 |
| container_title | APMIS : acta pathologica, microbiologica et immunologica Scandinavica |
| container_volume | 109 |
| creator | Lee, Je Chul Oh, Jae Young Kim, Ki Sung Jeong, Yong Wook Cho, Jae We Park, Jong Chun Seol, Sung Yong Cho, Dong Taek |
| description | Eighty-eight strains of Shigella sonnei isolated in Korea during the period 1980 to 1999 were tested for susceptibility to 13 antimicrobial agents. S. sonnei isolates demonstrated high frequencies of resistance to sulfamethoxazole (97.7%), tetracycline (96.6%), and trimethoprim (95.5%). S. sonnei isolates from the 1990s were more resistant to nalidixic acid than isolates from the 1980s (100 vs 7.7%), while isolates from the 1990s were more susceptible to chloramphenicol than isolates from the 1980s (0 vs 100%). Ampicillin-resistant S. sonnei isolates produced the TEM-1 beta-lactamase with a pI of 5.4. The TEM-1 gene was located on conjugally transferable plasmids in the majority of isolates. S. sonnei isolates were all susceptible to cefotaxime, cefoxitin, ceftazidime, ciprofloxacin, and norfloxacin. These results indicate that cephalosporins and quinolones may be alternative antibiotics for the treatment of S. sonnei infections in Korea. |
| doi_str_mv | 10.1034/j.1600-0463.2001.090307.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70969717</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70969717</sourcerecordid><originalsourceid>FETCH-LOGICAL-i275t-3b3badd865b9d6e651dbad975e55bed606fbe6a28261c3d9e4f032d2d94d72983</originalsourceid><addsrcrecordid>eNpF0F9PwjAQAPDGaATRr2Dqg75ttuu_7ZEQBZUoEY2PS7feoDg2bEfEb-8IiE-Xu_vlcncIXVESUsL47SKkkpCAcMnCiBAakoQwosLNEeoeOseouy0HXHLaQWfeL1oZxVKdog6lnBFBaBdN-lVjlzZ3dWZ1iR146xtd5YDrAk_ndgZlqbGvqwosthV-qh1obNbOVjPczAGX2je4-a6xgVwb8OfopNClh4t97KH3-7u3wSgYvwwfBv1xYCMlmoBlLNPGxFJkiZEgBTVtnigBQmRgJJFFBlJHcSRpzkwCvCAsMpFJuFFRErMeutnNXbn6aw2-SZfW59ttK6jXPlUkkYmiqoWXe7jOlmDSlbNL7X7Svx-04HoPtM91Wbj2fOv_HadCtXu0Lti59kOwOfS1-0ylYkqkH8_DlMePo9fJlKSU_QIInnxA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70969717</pqid></control><display><type>article</type><title>Antimicrobial resistance of Shigella sonnei in Korea during the last two decades</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Lee, Je Chul ; Oh, Jae Young ; Kim, Ki Sung ; Jeong, Yong Wook ; Cho, Jae We ; Park, Jong Chun ; Seol, Sung Yong ; Cho, Dong Taek</creator><creatorcontrib>Lee, Je Chul ; Oh, Jae Young ; Kim, Ki Sung ; Jeong, Yong Wook ; Cho, Jae We ; Park, Jong Chun ; Seol, Sung Yong ; Cho, Dong Taek</creatorcontrib><description>Eighty-eight strains of Shigella sonnei isolated in Korea during the period 1980 to 1999 were tested for susceptibility to 13 antimicrobial agents. S. sonnei isolates demonstrated high frequencies of resistance to sulfamethoxazole (97.7%), tetracycline (96.6%), and trimethoprim (95.5%). S. sonnei isolates from the 1990s were more resistant to nalidixic acid than isolates from the 1980s (100 vs 7.7%), while isolates from the 1990s were more susceptible to chloramphenicol than isolates from the 1980s (0 vs 100%). Ampicillin-resistant S. sonnei isolates produced the TEM-1 beta-lactamase with a pI of 5.4. The TEM-1 gene was located on conjugally transferable plasmids in the majority of isolates. S. sonnei isolates were all susceptible to cefotaxime, cefoxitin, ceftazidime, ciprofloxacin, and norfloxacin. These results indicate that cephalosporins and quinolones may be alternative antibiotics for the treatment of S. sonnei infections in Korea.</description><identifier>ISSN: 0903-4641</identifier><identifier>EISSN: 1600-0463</identifier><identifier>DOI: 10.1034/j.1600-0463.2001.090307.x</identifier><identifier>PMID: 11430501</identifier><language>eng</language><publisher>Copenhagen: Munksgaard International Publishers</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimicrobial susceptibility ; Bacteriology ; beta-Lactamases - biosynthesis ; beta-Lactamases - genetics ; Biological and medical sciences ; Chromosome Mapping ; Drug Resistance, Microbial ; Dysentery, Bacillary - genetics ; Dysentery, Bacillary - microbiology ; Epidemiology ; Fundamental and applied biological sciences. Psychology ; Genes, Bacterial ; Humans ; Korea ; Medical sciences ; Microbial Sensitivity Tests ; Microbiology ; Pharmacology. Drug treatments ; Shigella sonnei ; Shigella sonnei - drug effects ; Shigella sonnei - enzymology ; Shigella sonnei - genetics ; Shigella sonnei - isolation & purification ; ß-lactamase</subject><ispartof>APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2001-03, Vol.109 (3), p.228-234</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14157282$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11430501$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Je Chul</creatorcontrib><creatorcontrib>Oh, Jae Young</creatorcontrib><creatorcontrib>Kim, Ki Sung</creatorcontrib><creatorcontrib>Jeong, Yong Wook</creatorcontrib><creatorcontrib>Cho, Jae We</creatorcontrib><creatorcontrib>Park, Jong Chun</creatorcontrib><creatorcontrib>Seol, Sung Yong</creatorcontrib><creatorcontrib>Cho, Dong Taek</creatorcontrib><title>Antimicrobial resistance of Shigella sonnei in Korea during the last two decades</title><title>APMIS : acta pathologica, microbiologica et immunologica Scandinavica</title><addtitle>APMIS</addtitle><description>Eighty-eight strains of Shigella sonnei isolated in Korea during the period 1980 to 1999 were tested for susceptibility to 13 antimicrobial agents. S. sonnei isolates demonstrated high frequencies of resistance to sulfamethoxazole (97.7%), tetracycline (96.6%), and trimethoprim (95.5%). S. sonnei isolates from the 1990s were more resistant to nalidixic acid than isolates from the 1980s (100 vs 7.7%), while isolates from the 1990s were more susceptible to chloramphenicol than isolates from the 1980s (0 vs 100%). Ampicillin-resistant S. sonnei isolates produced the TEM-1 beta-lactamase with a pI of 5.4. The TEM-1 gene was located on conjugally transferable plasmids in the majority of isolates. S. sonnei isolates were all susceptible to cefotaxime, cefoxitin, ceftazidime, ciprofloxacin, and norfloxacin. These results indicate that cephalosporins and quinolones may be alternative antibiotics for the treatment of S. sonnei infections in Korea.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimicrobial susceptibility</subject><subject>Bacteriology</subject><subject>beta-Lactamases - biosynthesis</subject><subject>beta-Lactamases - genetics</subject><subject>Biological and medical sciences</subject><subject>Chromosome Mapping</subject><subject>Drug Resistance, Microbial</subject><subject>Dysentery, Bacillary - genetics</subject><subject>Dysentery, Bacillary - microbiology</subject><subject>Epidemiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genes, Bacterial</subject><subject>Humans</subject><subject>Korea</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Shigella sonnei</subject><subject>Shigella sonnei - drug effects</subject><subject>Shigella sonnei - enzymology</subject><subject>Shigella sonnei - genetics</subject><subject>Shigella sonnei - isolation & purification</subject><subject>ß-lactamase</subject><issn>0903-4641</issn><issn>1600-0463</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0F9PwjAQAPDGaATRr2Dqg75ttuu_7ZEQBZUoEY2PS7feoDg2bEfEb-8IiE-Xu_vlcncIXVESUsL47SKkkpCAcMnCiBAakoQwosLNEeoeOseouy0HXHLaQWfeL1oZxVKdog6lnBFBaBdN-lVjlzZ3dWZ1iR146xtd5YDrAk_ndgZlqbGvqwosthV-qh1obNbOVjPczAGX2je4-a6xgVwb8OfopNClh4t97KH3-7u3wSgYvwwfBv1xYCMlmoBlLNPGxFJkiZEgBTVtnigBQmRgJJFFBlJHcSRpzkwCvCAsMpFJuFFRErMeutnNXbn6aw2-SZfW59ttK6jXPlUkkYmiqoWXe7jOlmDSlbNL7X7Svx-04HoPtM91Wbj2fOv_HadCtXu0Lti59kOwOfS1-0ylYkqkH8_DlMePo9fJlKSU_QIInnxA</recordid><startdate>20010301</startdate><enddate>20010301</enddate><creator>Lee, Je Chul</creator><creator>Oh, Jae Young</creator><creator>Kim, Ki Sung</creator><creator>Jeong, Yong Wook</creator><creator>Cho, Jae We</creator><creator>Park, Jong Chun</creator><creator>Seol, Sung Yong</creator><creator>Cho, Dong Taek</creator><general>Munksgaard International Publishers</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20010301</creationdate><title>Antimicrobial resistance of Shigella sonnei in Korea during the last two decades</title><author>Lee, Je Chul ; Oh, Jae Young ; Kim, Ki Sung ; Jeong, Yong Wook ; Cho, Jae We ; Park, Jong Chun ; Seol, Sung Yong ; Cho, Dong Taek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i275t-3b3badd865b9d6e651dbad975e55bed606fbe6a28261c3d9e4f032d2d94d72983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimicrobial susceptibility</topic><topic>Bacteriology</topic><topic>beta-Lactamases - biosynthesis</topic><topic>beta-Lactamases - genetics</topic><topic>Biological and medical sciences</topic><topic>Chromosome Mapping</topic><topic>Drug Resistance, Microbial</topic><topic>Dysentery, Bacillary - genetics</topic><topic>Dysentery, Bacillary - microbiology</topic><topic>Epidemiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genes, Bacterial</topic><topic>Humans</topic><topic>Korea</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Shigella sonnei</topic><topic>Shigella sonnei - drug effects</topic><topic>Shigella sonnei - enzymology</topic><topic>Shigella sonnei - genetics</topic><topic>Shigella sonnei - isolation & purification</topic><topic>ß-lactamase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Je Chul</creatorcontrib><creatorcontrib>Oh, Jae Young</creatorcontrib><creatorcontrib>Kim, Ki Sung</creatorcontrib><creatorcontrib>Jeong, Yong Wook</creatorcontrib><creatorcontrib>Cho, Jae We</creatorcontrib><creatorcontrib>Park, Jong Chun</creatorcontrib><creatorcontrib>Seol, Sung Yong</creatorcontrib><creatorcontrib>Cho, Dong Taek</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>APMIS : acta pathologica, microbiologica et immunologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Je Chul</au><au>Oh, Jae Young</au><au>Kim, Ki Sung</au><au>Jeong, Yong Wook</au><au>Cho, Jae We</au><au>Park, Jong Chun</au><au>Seol, Sung Yong</au><au>Cho, Dong Taek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial resistance of Shigella sonnei in Korea during the last two decades</atitle><jtitle>APMIS : acta pathologica, microbiologica et immunologica Scandinavica</jtitle><addtitle>APMIS</addtitle><date>2001-03-01</date><risdate>2001</risdate><volume>109</volume><issue>3</issue><spage>228</spage><epage>234</epage><pages>228-234</pages><issn>0903-4641</issn><eissn>1600-0463</eissn><abstract>Eighty-eight strains of Shigella sonnei isolated in Korea during the period 1980 to 1999 were tested for susceptibility to 13 antimicrobial agents. S. sonnei isolates demonstrated high frequencies of resistance to sulfamethoxazole (97.7%), tetracycline (96.6%), and trimethoprim (95.5%). S. sonnei isolates from the 1990s were more resistant to nalidixic acid than isolates from the 1980s (100 vs 7.7%), while isolates from the 1990s were more susceptible to chloramphenicol than isolates from the 1980s (0 vs 100%). Ampicillin-resistant S. sonnei isolates produced the TEM-1 beta-lactamase with a pI of 5.4. The TEM-1 gene was located on conjugally transferable plasmids in the majority of isolates. S. sonnei isolates were all susceptible to cefotaxime, cefoxitin, ceftazidime, ciprofloxacin, and norfloxacin. These results indicate that cephalosporins and quinolones may be alternative antibiotics for the treatment of S. sonnei infections in Korea.</abstract><cop>Copenhagen</cop><pub>Munksgaard International Publishers</pub><pmid>11430501</pmid><doi>10.1034/j.1600-0463.2001.090307.x</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0903-4641 |
| ispartof | APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2001-03, Vol.109 (3), p.228-234 |
| issn | 0903-4641 1600-0463 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70969717 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Anti-Bacterial Agents - pharmacology Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Antimicrobial susceptibility Bacteriology beta-Lactamases - biosynthesis beta-Lactamases - genetics Biological and medical sciences Chromosome Mapping Drug Resistance, Microbial Dysentery, Bacillary - genetics Dysentery, Bacillary - microbiology Epidemiology Fundamental and applied biological sciences. Psychology Genes, Bacterial Humans Korea Medical sciences Microbial Sensitivity Tests Microbiology Pharmacology. Drug treatments Shigella sonnei Shigella sonnei - drug effects Shigella sonnei - enzymology Shigella sonnei - genetics Shigella sonnei - isolation & purification ß-lactamase |
| title | Antimicrobial resistance of Shigella sonnei in Korea during the last two decades |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T11%3A03%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20resistance%20of%20Shigella%20sonnei%20in%20Korea%20during%20the%20last%20two%20decades&rft.jtitle=APMIS%20:%20acta%20pathologica,%20microbiologica%20et%20immunologica%20Scandinavica&rft.au=Lee,%20Je%20Chul&rft.date=2001-03-01&rft.volume=109&rft.issue=3&rft.spage=228&rft.epage=234&rft.pages=228-234&rft.issn=0903-4641&rft.eissn=1600-0463&rft_id=info:doi/10.1034/j.1600-0463.2001.090307.x&rft_dat=%3Cproquest_pubme%3E70969717%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70969717&rft_id=info:pmid/11430501&rfr_iscdi=true |